A Look at the Innovations Introduced by the 2014 FOYA Category Winners
The 2014 Facility of the Year Awards program is shaping up to be one of the most noteworthy events of the year. A few weeks ago, we talked about what the pharmaceutical and biopharmaceutical industry can learn from the facilities recognized by FOYA. Category Winners have been announced and this year’s winning projects showcase some amazing innovations.
The category winners are:
Boehringer Ingelheim Pharma GmbH & Co. KG: Winner of the Facility of the Year Award for Equipment Innovation
F. Hoffmann-La Roche: Winner of the Facility of the Year Award for Sustainability
Grifols Therapeutics, Inc.: Winner of the Facility of the Year Award for Project Execution
Patheon Pharma Services (formerly DSM Biologics): Winner of the Facility of the Year Award for Process Innovation
Penn Pharmaceutical Services Ltd.: Winner of the Facility of the Year Award for Facility Integration
Pfizer Ireland Pharmaceuticals: Winner of the Facility of the Year Award for Operational Excellence
The FOYA Judging Panel also chose to award an Honorable Mention to WuXi AppTec Biopharmaceutical for their recently completed flexible CGMP bulk cell culture production facility. The facility, consisting of two parallel upstream cell culture bioreactor lines with flexible working volumes of 50l through 2,000l bioreactors and one downstream purification production line is the most advanced such facility built in the People’s Republic of China.
Pharmaceutical manufacturing sites that export their products around the world are often subjected to many GMP inspections each year by different regulatory authorities, with a significant number of these being duplicate, same-scope inspections. This is...
Asia Pacific Pharma Outlook
The healthcare market in the Asia Pacific (APAC) region is continuing to grow at a steady rate with an estimated 500-billion-dollar industry by 2020. This is due to rising development in smart manufacturing and government...